Critical illness and the hepatic microcirculation: A review

Intensive Care Medicine: Annual Update 2007

Volumn , Issue , 2007, Pages 643-650

  Van Der Hoven, B ^a   Gommers, D ^a   Bakker, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892098938     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-49518-7_57     Document Type: Chapter

References (32)

1. Ceppa EP, Fuh KC, Bulkley GB (2003). Mesenteric hemodynamic response to circulatory shock. Curr Opin Crit Care 9:127-132
2. Vallet B (1998) Vascular reactivity and tissue oxygenation. Intensive Care Med 24:3-11
3. Hiltebrand LB, Krejci V, Banic A, Erni D, Wheatley AM, Sigurdsson GH (2000) Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. CritCare Med 28:3233-3241
4. Verdant C, De Backer D (2005) How monitoring of the microcirculation may help us at the bedside. Curr Opin Crit Care 11:240-244
5. Oda M, Yokomori H, Han JY (2003) Regulatory mechanisms of hepatic microcirculation. Clin Hemorheol Microcirc 29:167-182
6. Wunder C, Roewer N, Eichelbronner O (2004) Main determinants of liver microcirculation during systemic inflammation. Anaesthesist 53:1073-1085
7. Rappaport AM (1980) Hepatic blood flow: morphologic aspects and physiologic regulation. Int Rev Physiol 21:1-63
8. Portmann BC (2000) Anatomy of the normal liver. In: O'Grady JG, Lake JR, Howdle PD (eds) Comprehensive Clinical Hepatology. London, Mosby, pp 1-14
9. Oda M, Yokomori H, Han JY (2006) Regulatory mechanisms of hepatic microcirculatory hemodynamics: hepatic arterial system. Clin Hemorheol Microcirc 34:11-26
10. Bauer A, Bruegger D, Christ F (2005) Microcirculatory monitoring of sepsis. Anaesthesist 54:1163-1175
11. Colle I, Van Vlierberghe H, Troisi R, De Hemptinne B (2004) Transplanted liver: consequences of denervation for liver functions. Anat Rec A Discov Mol Cell Evol Biol 280:924-931
12. Alexander B, Cottam H, Naftalin R (2001) Hepatic arterial perfusion regulates portal venous flow between hepatic sinusoids and intrahepatic shunts in the normal rat liver in vitro. Pfiu-gers Arch 443:257-264
13. Alexander B, Rogers C, Naftalin R (2002) Hepatic arterial perfusion decreases intrahepatic shunting and maintains glucose uptake in the rat liver. Pflugers Arch 444:291-298
14. Yokoyama Y, Wawrzyniak A, Sarmadi AM, et al (2006) Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats. J Gastroenterol Hepatol 21:1567-1574
15. Jakab F, Sugar I, Rath Z, Nagy P, Faller J (1996) The relationship between portal venous and hepatic arterial blood flow. I. Experimental liver transplantation. HPB Surg 10:21-26
16. Oda M, Han JY, Nakamura M (2000) Endothelial cell dysfunction in microvasculature: relevance to disease processes. Clin Hemorheol Microcirc 23:199-211
17. Reynaert H, Thompson MG, Thomas T, Geerts A (2002) Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50:571-581
18. Chen T, Zamora R, Zuckerbraun B, Billiar TR (2003) Role of nitric oxide in liver injury. Curr MolMed 3:519-526
19. Li X, Benjamin IS, Alexander B (2003) The role of nitric oxide in systemic and hepatic hae-modynamics in the rat in vivo. Naunyn Schmiedebergs Arch Pharmacol 368:142-149
20. Taylor BS, Alarcon LH, Billiar TR (1998) Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc) 63:766-781
21. Lhuillier F, Robert MO, Crova P, et al (2006) Nitric oxide and liver microcirculation during autoregulation and haemorrhagic shock in rabbit model. Br J Anaesth 97:137-146
22. Nijveldt RJ, Siroen MP, Teerlink T, van Lambalgen AA, Rauwerda JA, van Leeuwen PA (2004) Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int 24:510-518
23. Nijveldt RJ, Siroen MP, Teerlink T, van Leeuwen PA (2004) Elimination of asymmetric dimethylarginine by the kidney and the liver: a link to the development of multiple organ failure? J Nutr 134 (Suppl 10):2848S-2852S
24. Nijveldt RJ, Teerlink T, Van Der Hoven B, at al (2003) Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22:23-30
25. Nijveldt RJ, Siroen MP, van der Hoven B, et al (2004) High plasma arginine concentrations in critically ill patients suffering from hepatic failure. Eur J Clin Nutr 58:587-593
26. Dallinger S, Sieder A, Strametz J, Bayerle-Eder M, Wolzt M, Schmetterer L (2003) Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans. Am J Physiol Endocrinol Metab 284.-E1106-1111
27. Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den Berghe G (2005) Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33:504-510
28. Fondevila C, Busuttil RW, Kupiec-Weglinski JW (2003) Hepatic ischemia/reperfusion injury-A fresh look. Exp Mol Pathol 74:86-93
29. Kupiec-Weglinski JW, Busuttil RW (2005) Ischemia and reperfusion injury in liver transplantation. Transplant Proc 37:1653-1656
30. Brems JJ (2006) Ischemia-reperfusion: putting the pieces of the puzzle together. Crit Care Med 34:1570-1571
31. Khandoga A, Biberthaler P, Enders G, Krombach F (2004) 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion. Crit Care Med 32:472-477
32. Roesner JP, Vagts DA, Iber T, Eipel C, Vollmar B, Noldge-Schomburg GF (2006) Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats. Intensive Care Med 32:1649-1657